Moiseenko, F. V., Krasavina, M. A., Agranov, I. R., Artemieva, E. V., Oganesian, A. P., Gabina, A. S., . . . Zamaraev, A. V. Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients. BMC.
Chicago Style (17th ed.) CitationMoiseenko, F. V., et al. Prognostic Model Integrating Histology, Systemic Inflammation, and Recurrence Status Predicts Immunotherapy Response in Advanced Non-small-cell Lung Cancer Patients. BMC.
MLA (9th ed.) CitationMoiseenko, F. V., et al. Prognostic Model Integrating Histology, Systemic Inflammation, and Recurrence Status Predicts Immunotherapy Response in Advanced Non-small-cell Lung Cancer Patients. BMC.
Warning: These citations may not always be 100% accurate.